China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,059,517 | $86,204 | $32,738 | $35,781 |
| Dep. & Amort. | $57,634 | $11,101 | $6,232 | $6,269 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $221,959 | $0 | -$11,512 | $0 |
| Other Non-Cash | -$453,597 | -$19,683 | $14,403 | -$18,652 |
| Operating Cash Flow | $885,512 | $77,623 | $41,861 | $23,398 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$129,861 | -$10,251 | -$6,518 | -$3,578 |
| Net Acquisitions | $263 | $720 | $0 | $0 |
| Inv. Purchases | -$844,997 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $527,613 | $0 | $0 | $0 |
| Other Inv. Act. | $163,920 | $20,483 | $6,768 | -$294 |
| Investing Cash Flow | -$283,062 | $10,952 | $250 | -$3,873 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $21,676 | $8,324 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$317,787 | -$90,129 | -$5,691 | -$17,049 |
| Other Fin. Act. | -$9,411 | -$5,148 | -$419 | $21,598 |
| Financing Cash Flow | -$350,955 | -$41,520 | -$6,110 | $4,549 |
| Forex Effect | -$47,755 | $582 | -$102 | $556 |
| Net Chg. in Cash | $251,377 | $0 | $35,899 | $24,631 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,888,776 | $830,092 | $0 | $0 |
| End Cash | $6,140,153 | $857,738 | $35,899 | $24,631 |
| Free Cash Flow | $755,651 | $67,372 | $35,343 | $19,820 |